The role of high density lipoprotein in sepsis

Netherlands Journal of Medicine

Volumn 59, Issue 3, 2001, Pages 102-110

  Van Leeuwen, Henk J ^a   Van Beek, André P ^a   Dallinga Thie, Geesje M ^a   Van Strijp, Jos A G ^a   Verhoef, Jan ^a   Van Kessel, Kok P M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; APOLIPOPROTEIN A; APOPROTEIN; C REACTIVE PROTEIN; CD14 ANTIGEN; CHEMOTACTIC FACTOR; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; CHOLESTEROL ESTERASE; CHYLOMICRON; CLUSTERIN; ENDOTOXIN; G PROTEIN COUPLED RECEPTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEIN; RANTES; SCAVENGER RECEPTOR; SERUM AMYLOID A; TISSUE FACTOR PATHWAY INHIBITOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

CHOLESTEROL TRANSPORT; DETOXIFICATION; HUMAN; IMMUNITY; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; LIVER CLEARANCE; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; REVIEW; SEPSIS; SEPTIC SHOCK;

HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; LIPOPROTEINS, HDL; MONOCYTES; SEPSIS;

EID: 0034802286     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(01)00144-9     Document Type: Article

References (83)

1. Current understanding of sepsis
2. Why sepsis trials fail
3. Efficacy and safety of recombinant human activated protein C for severe sepsis
4. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock
5. The protective effect of serum lipoproteins against bacterial lipopolysaccharide
6. Low lipid concentrations in critical illness: Implications for preventing and treating endotoxemia
7. Changes in serum lipoprotein pattern induced by acute infections
8. Hyperlipoproteinemias and other disorders of lipid metabolism
9. Disorders of lipoprotein metabolism
10. High density lipoprotein metabolism
11. Molecular physiology of reverse cholesterol transport
12. Infection and inflammation-induced proatherogenic changes of lipoproteins
13. Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS
14. Biochemical characterization of recombinant fusions of lipopolysaccharide binding protein and bactericidal/permeability- increasing protein. Implications in biological activity
15. Structure and function of lipopolysaccharide binding protein
16. Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s)
17. Control of lipopolysaccharide-high-density lipoprotein interactions by an acute-phase reactant in human serum
18. A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis
19. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein
20. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS
21. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14
22. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
23. Isolation and characterization of the amyloid-related apoprotein (SAA) from human high density lipoprotein
24. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen
25. Molecular and cellular biology of serum amyloid A
26. Serum amyloid A protein - Current status
27. Human serum amyloid A (SAA) protein: A prominent acute-phase reactant for clinical practice
28. Characterization of high affinity binding between laminin and the acute-phase protein, serum amyloid A
29. Secretion of serum amyloid protein and assembly of serum amyloid protein-rich high density lipoprotein in primary mouse hepatocyte culture
30. Acute phase serum amyloid A (SAA) and cholesterol transport during acute inflammation: A hypothesis
31. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein
32. Acute-phase proteins and other systemic responses to inflammation
33. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins
34. HDL content and composition in acute phase response in three species: Triglyceride enrichment of HDL a factor in its decrease
35. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition
36. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function
37. Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions
38. Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance
39. Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice
40. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor
41. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels
42. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism
43. Macrophage scavenger receptor class A - A multifunctional receptor in atherosclerosis
44. Recognition and plasma clearance of endotoxin by scavenger receptors
45. Scavenger receptors in innate immunity
46. The acute phase response in Syrian hamsters elevates apolipoprotein serum amyloid A (apoSAA) and disrupts lipoprotein metabolism
47. Serum amyloid A (SAA): Influence on HDL-mediated cellular cholesterol efflux
48. Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells
49. Recombinant human serum amyloid A (apoSAAp) binds cholesterol and modulates cholesterol flux
50. Association between serum amyloid A proteins and coronary artery disease: Evidence from two distinct arteriosclerotic processes
51. Mechanisms of disease - Atherosclerosis - An inflammatory disease
52. Binding of human serum amyloid A (hSAA) and its high-density lipoprotein3 complex (hSAA-HDL3) to human neutrophils. Possible implication to the function of a protein of an unknown physiological role
53. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein
54. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells
55. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway
56. Interactions of bacterial lipopolysaccharide with acute-phase rabbit serum and isolation of two forms of rabbit serum amyloid A
57. The role of serum amyloid A in sepsis and LPS neutralization
58. The pathogenesis of sepsis
59. Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways
60. Brief report: Shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin
61. Reduction of febrile response to bacterial polysaccharide following incubation with serum
62. The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum
63. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits
64. New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma
65. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides
66. Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats
67. Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins
68. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum
69. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins
70. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide
71. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins
72. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I
73. LPS induced release of IL-1 beta, IL-6, IL-8 and TNF-alpha in EDTA or heparin anticoagulated whole blood from persons with high or low levels of serum HDL
74. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood
75. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death
76. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice
77. Protective effects of reconstituted high-density lipoprotein in rabbit gram-negative bacteremia models
78. Reconstituted high density lipoprotein inhibits physiologic and tumor necrosis factor alpha responses to lipopolysaccharide in rabbits
79. In vivo protection against endotoxin by plasma high density lipoprotein
80. Phospholipid rich emulsion improved survival and cardiovascular status in porcine septic shock in a dose-dependent manner
81. Role for circulating lipoproteins in protection from endotoxin toxicity
82. Therapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock
83. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia